Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)

NCT03198728 is registered in ClinicalTrials.gov with Marius Pharmaceuticals as lead sponsor.

NCT NCT03198728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03198728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
Lead sponsor
Marius Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
July 5, 2017
Completion date
May 1, 2020
Enrollment
314 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism, male